Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
- PMID: 32683322
- PMCID: PMC7362820
- DOI: 10.1016/j.dsx.2020.07.015
Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
Keywords: Anticoagulant; COVID-19; Diabetes mellitus; Hypercoagulable state; Obesity.
Conflict of interest statement
Declaration of competing interest The authors declare that there is no conflict of interest regarding the publication of this article.
References
-
- Huang I., Lim M.A., Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression: Diabetes and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14:395–403. doi: 10.1016/j.dsx.2020.04.018. - DOI - PMC - PubMed
